Position in MRK
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$10,281,908
+$3,498,533 QoQ
Shares Held
85,476
+32.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Brooklyn Investment Group holds $115,864,558 across 14 Drug Manufacturers - General names. MRK ranks #5 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
21,894 | $20,137,444 | |
| 2 | JNJ |
Johnson & Johnson
|
72,598 | $17,745,855 | |
| 3 | NVS |
Novartis AG
|
96,271 | $14,705,395 | |
| 4 | ABBV |
AbbVie Inc.
|
63,195 | $13,744,280 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
85,476 | $10,281,908 | |
| 6 | AMGN |
Amgen Inc
|
24,742 | $8,705,472 | |
| 7 | GSK |
GSK plc
|
121,594 | $6,710,772 | |
| 8 | AZN |
Astrazeneca PLC
|
24,472 | $4,826,367 |
All Filings in MRK
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,281,908 | 85,476 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $6,783,375 | 64,444 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $2,612,489 | 31,127 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,508,026 | 31,683 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,043,835 | 22,770 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,111,291 | 11,171 | Shares | Defined | 2025-01-15 | |
| 2024-09-30 | $1,585,865 | 13,965 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,666,348 | 13,460 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $1,776,047 | 13,460 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $1,449,202 | 13,293 | Shares | Defined | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||